BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15600380)

  • 41. Cardiovascular effects of antipsychotics.
    Michelsen JW; Meyer JM
    Expert Rev Neurother; 2007 Jul; 7(7):829-39. PubMed ID: 17610390
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outcome evaluation of a structured educational wellness program in patients with severe mental illness.
    Lindenmayer JP; Khan A; Wance D; Maccabee N; Kaushik S; Kaushik S
    J Clin Psychiatry; 2009 Oct; 70(10):1385-96. PubMed ID: 19778494
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The metabolic syndrome among postmenopausal women in Ecuador.
    Hidalgo LA; Chedraui PA; Morocho N; Alvarado M; Chavez D; Huc A
    Gynecol Endocrinol; 2006 Aug; 22(8):447-54. PubMed ID: 17012107
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiometabolic comorbidity in antipsychotic treated patients: need for systematic evaluation and treatment.
    Steylen PM; van der Heijden FM; Kok HD; Sijben NA; Verhoeven WM
    Int J Psychiatry Clin Pract; 2013 Jun; 17(2):125-30. PubMed ID: 23437800
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolic syndrome & obesity: co-epidemics could overwhelm home health care.
    Pearce LC
    Caring; 2003 Jun; 22(6):24-8, 30, 32-3; quiz 34-6. PubMed ID: 12905569
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolic complications of schizophrenia and antipsychotic medications--an updated review.
    Yogaratnam J; Biswas N; Vadivel R; Jacob R
    East Asian Arch Psychiatry; 2013 Mar; 23(1):21-8. PubMed ID: 23535629
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Metabolic syndrome: protective obesity].
    Nau JY
    Rev Med Suisse; 2010 Mar; 6(241):644-5. PubMed ID: 20408371
    [No Abstract]   [Full Text] [Related]  

  • 48. Cardiovascular aspects of antipsychotics.
    Raedler TJ
    Curr Opin Psychiatry; 2010 Nov; 23(6):574-81. PubMed ID: 20838345
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Swedish clinical guidelines--prevention and management of metabolic risk in patients with severe psychiatric disorders.
    Gothefors D; Adolfsson R; Attvall S; Erlinge D; Jarbin H; Lindström K; von Hausswolff-Juhlin YL; Morgell R; Toft E; Osby U;
    Nord J Psychiatry; 2010 Oct; 64(5):294-302. PubMed ID: 20662682
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Medical consequences of obesity.
    Lawrence VJ; Kopelman PG
    Clin Dermatol; 2004; 22(4):296-302. PubMed ID: 15475229
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Obesity, psychiatric status, and psychiatric medications.
    Berkowitz RI; Fabricatore AN
    Psychiatr Clin North Am; 2011 Dec; 34(4):747-64. PubMed ID: 22098801
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Medical illness in patients with schizophrenia.
    Goldman LS
    J Clin Psychiatry; 1999; 60 Suppl 21():10-5. PubMed ID: 10548136
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Schizophrenia and antipsychotics associated with the metabolic syndrome. An overview].
    Scheepers-Hoeks AM; Wessels-Basten SJ; Scherders MJ; Bravenboer B; Loonen AJ; Kleppe RT; Grouls RJ
    Tijdschr Psychiatr; 2008; 50(10):645-54. PubMed ID: 18951343
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Type 2 diabetes: fueling the surge of cardiovascular disease in women.
    Jones EJ; Appel SJ
    Nurs Womens Health; 2008 Dec; 12(6):500-13; quiz 514. PubMed ID: 19121055
    [No Abstract]   [Full Text] [Related]  

  • 55. [Affective disorders: endocrine and metabolic comorbidities].
    Cermolacce M; Belzeaux R; Adida M; Azorin JM
    Encephale; 2014 Dec; 40 Suppl 3():S33-9. PubMed ID: 25550238
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabolic syndrome in psychiatrically hospitalized patients treated with antipsychotics and other psychotropics.
    Centorrino F; Masters GA; Talamo A; Baldessarini RJ; Öngür D
    Hum Psychopharmacol; 2012 Sep; 27(5):521-6. PubMed ID: 22996619
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Schizophrenia, the metabolic syndrome and diabetes.
    Holt RI; Peveler RC; Byrne CD
    Diabet Med; 2004 Jun; 21(6):515-23. PubMed ID: 15154933
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metabolic issues in patients with severe mental illness.
    Citrome L; Blonde L; Damatarca C
    South Med J; 2005 Jul; 98(7):714-20. PubMed ID: 16108240
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevention of metabolic syndrome in serious mental illness.
    Ganguli R; Strassnig M
    Psychiatr Clin North Am; 2011 Mar; 34(1):109-25. PubMed ID: 21333843
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The incidence of metabolic risk factors in an inpatient psychiatric setting.
    Coakley C; Bolton P; Flaherty L; Kopeski LM; Slifka K; Sutherland MA
    J Psychosoc Nurs Ment Health Serv; 2012 Mar; 50(3):24-30. PubMed ID: 22329619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.